Titomic (TTT) Transition period summary

Executive summary

• Transitioned to a six-month reporting period ending 31 December 2025, aligning with U.S. and Netherlands subsidiaries.

• Focused on scaling U.S. and European operations, with new facilities in Huntsville, Alabama and Heerenveen, Netherlands now operational.

• Strategic emphasis on defense, aerospace, semiconductor, and energy sectors, leveraging patented cold spray technology.

• Key milestones include successful defense and semiconductor contracts, and validation of technology by major clients.

Financial highlights

• Revenue for the six months ended 31 December 2025 was $5.27 million, compared to $9.43 million for the 12 months ended 30 June 2025.

• Net loss after tax for the six months was $17.85 million, compared to a $19.89 million loss for the prior 12 months.

• Cash at period end was $35.77 million, up from $8.93 million at 30 June 2025, following a $50 million capital raise.

• Total expenses for the six months were $23.12 million, with significant investment in U.S. production capacity and operational scaling.

• No dividends declared or paid.

Outlook and guidance

• Anticipates material revenue growth in 2026, driven by defense and energy sector contracts and machine sales.

• Management targets significant progress toward annualized operating cash flow breakeven in 2027.

• Expects reduced quarterly cash burn as new facilities reach full operational status.